Details of the primary studies for functionality and joint ROM
Study | Treatment | Biofeedback mode | EMG device | Outcome parameter | Outcome values | ES | |
---|---|---|---|---|---|---|---|
EMG FB Group | Control Group | ||||||
[16] | 8 weeks (daily)
| Visual
| Myomed 134 | KOOS ADL | Pre:29.92 ± 11.72Post:66.83 ± 7.40 | Pre:27.74 ± 9.62Post:64.05 ± 8.48 | 0.35 |
KOOS sport and recreation function | Pre:6.37 ± 5.26Post:88.41 ± 8.57 | Pre:7.03 ± 6.51Post:83.24 ± 9.29 | 0.58* | ||||
KOOS quality of life | Pre:27.45 ± 7.38Post:90.54 ± 10.39 | Pre:29.63 ± 5.72Post:88.76 ± 9.54 | 0.18 | ||||
[21] | 8 weeks (2 times per week)
| Not specified
| Myomed 932 | MODQ | Pre:32.00 ± 5.02Post:2.66 ± 3.04 | Pre:32.04 ± 4.73Post:6.80 ± 3.44 | 1.28* |
[17] | 8 weeks (12 × 15 min sessions)
| Visual & acoustic
| MyoTrac Infiniti | WOMAC stiffness | Pre:1.8 ± 1.7Post:1.2 ± 1.2 | Pre:2.3 ± 1.6Post:1.7 ± 1. 1 | 0.43 |
WOMAC function | Pre:19.8 ± 13.0Post:14.6 ± 10.7 | Pre:22.4 ± 11.6Post:17.8 ± 9.4 | 0.32 | ||||
Lequesne walking | Pre:1.7 ± 1.5Post:1.2 ± 1.2 | Pre:1.6 ± 1. 1Post:1.3 ± 0.8 | 0.10 | ||||
Lequesne ADL | Pre:3.7 ± 1.8Post:3.1 ± 1.6 | Pre:3.6 ± 1.3Post:3.0 ± 1. 1 | 0.07 | ||||
[18] | 3 weeks (3 times every day)
| Visual & acoustic
| Myomed 932 | WOMAC stiffness | Pre:4.31 ± 1.7Post:3.42 ± 1.57 | Pre:4.15 ± 1.81Post:3.0 ± 8.07 | 0.07 |
WOMAC function | Pre:49. 1 ± 12.44Post:33.42 ± 11.74 | Pre:47.6 ± 0.07Post:32.45 ± 9.08 | 0.09 | ||||
NHPS physical mobility | Pre:45.03 ± 21.46Post:28.10 ± 17.08 | Pre:37.59 ± 21.15Post:25.33 ± 18.41 | 0.16 | ||||
[19] | 4 weeks (2 times per week)
| Visual
| mDurance system | ROM abduction | Pre:100.8 ± 3.8Post:114.5 ± 5.8 | Pre:100.7 ± 3.4Post:109.8 ± 2.6 | 1.03* |
ROM external rotation | Pre:59.6 ± 6.9Post:74.0 ± 3.2 | Pre:59. 1 ± 7.9Post:66.9 ± 7.2 | 1.29* | ||||
[20] | 6 weeks (3 times per week)
| Visual & acoustic
| NeuroTrac MyoPlus4 Pro | ROM flexion | Pre:121. 11 ± 17.45Post:137.50 ± 18.16 | Pre:118.88 ± 23.92Post:135.55 ± 19.47 | 0.10* |
ROM abduction | Pre:121.82 ± 21.96Post:133.64 ± 18.17 | Pre:109.57 ± 25.35Post:127.89 ± 18.24 | 0.32 | ||||
ROM external rotation | Pre:45.83 ± 9.74Post:58.89 ± 6.76 | Pre:45.00 ± 10.58Post:59.17 ± 6.69 | 0.04 | ||||
ROM internal rotation | Pre:30.83 ± 5.05Post:35.83 ± 6.02 | Pre:28.44 ± 6.42Post:37.50 ± 4.92 | 0.30 |
* Significant effects between EMG FB Group and Control Group post intervention. ES: effect size; VL: vastus lateralis muscle; VM: vastus medialis muscle; BF: biceps femoris muscle; SM: semimembranosus muscle; RA: rectus abdominis muscle; KOOS: Knee Injury and Osteoarthritis Outcome Score; MODQ: Modified Oswestry Disability Questionnaire; WOMAC: Western Ontario and McMaster Universities osteoarthritis index; ADL: activities of daily living; NHPS: Nottingham Health Profile Score; AD: anterior deltoid muscle; SP: supraspinatus muscle; ROM: range of motion